Hence, it is plausible that the release of TFs FOS, FOSB, and JUNB by C6 S100A4+ SMCs contributes to exacerbating cardiomyopathies, potentially through the induction of cardiac fibrosis and inflammation. The gene discussed is FOS; the disease is cardiomyopathy.